Clinical Trial

Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated February 25, 2026 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study was to determine the effectiveness of a combination of intranasal conditioned medium (CM) with intraparenchymal umbilical cord mesenchymal stem cells (UC-MSCs) transplantation in acute stroke patients to induce neurogenesis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-08-09; most recent amendment 2026-02-23.
Status change: Recruiting → Active, Not Recruiting 2026-02-23
Status change: Not Yet Recruiting → Recruiting 2022-09-23
Trial Details
NCT Number NCT05008588
Lead Sponsor PT. Prodia Stem Cell Indonesia
Conditions Ischemic Stroke
Enrollment 15 participants
Start Date 2022-05-30
Primary Completion 2026-03 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-25